신경과용 색전술 장치 시장 규모, 점유율, 동향 및 성장 분석 보고서(2026-2034년)

The Embolization Devices For Neurology Market size is expected to reach USD 3.24 Billion in 2034 from USD 1.84 Billion (2025) growing at a CAGR of 6.48% during 2026-2034.

The global embolization devices for neurology market is expanding due to the increasing prevalence of neurological disorders such as brain aneurysms and arteriovenous malformations. These conditions often require minimally invasive procedures where embolization devices are used to block abnormal blood vessels. Rising awareness about early diagnosis and treatment of neurological conditions has significantly increased the demand for these specialized medical devices.

Technological advancements in neurovascular intervention have played a key role in market growth. The development of advanced coils, liquid embolic agents, and flow-diverting devices has improved treatment precision and patient outcomes. Additionally, the growing number of neurovascular treatment centers and increased adoption of minimally invasive procedures are supporting the demand for embolization technologies.

In the coming years, the market is expected to benefit from continuous innovation in neurointerventional devices and increasing investments in neurological research. The rising burden of neurological diseases and expanding healthcare infrastructure in emerging economies are also likely to drive market expansion. As medical technology advances, embolization procedures are expected to become safer and more widely accessible.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Product

• Embolization Coils
• Liquid Embolic Systems
• Flow Diversion Stents
• Aneurysm Clips
• Other Products

By Treatment

• Ischemic Stroke Solution
• Hemorrhagic Stroke Solutions

By Indication

• Brain Aneurysms
• Arteriovenous Malformation
• Other Indications

By End User

• Hospitals
• Ambulatory Surgical Centers
• Other End Users

COMPANIES PROFILED

• Johnson Johnson, Abbott Laboratories, Medtronic plc, Heraeus Holding, Stryker Corporation, Boston Scientific Corporation, Kaneka Corporation, Terumo Corporation, B Braun Melsungen AG, Cook Medical LLC, Integer Holdings Corporation, Merit Medical Systems Inc, Penumbra Inc, Asahi Intecc Co Ltd, MicroVention Inc
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL EMBOLIZATION DEVICES FOR NEUROLOGY MARKET: BY PRODUCT 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Product
• 4.2. Embolization Coils Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Liquid Embolic Systems Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Flow Diversion Stents Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.5. Aneurysm Clips Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.6. Other Products Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL EMBOLIZATION DEVICES FOR NEUROLOGY MARKET: BY TREATMENT 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Treatment
• 5.2. Ischemic Stroke Solution Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Hemorrhagic Stroke Solutions Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL EMBOLIZATION DEVICES FOR NEUROLOGY MARKET: BY INDICATION 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast Indication
• 6.2. Brain Aneurysms Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Arteriovenous Malformation Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Other Indications Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL EMBOLIZATION DEVICES FOR NEUROLOGY MARKET: BY END USER 2022-2034 (USD MN)

• 7.1. Market Analysis, Insights and Forecast End User
• 7.2. Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.3. Ambulatory Surgical Centers Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.4. Other End Users Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL EMBOLIZATION DEVICES FOR NEUROLOGY MARKET: BY REGION 2022-2034(USD MN)

• 8.1. Regional Outlook
• 8.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.2.1 By Product
  • 8.2.2 By Treatment
  • 8.2.3 By Indication
  • 8.2.4 By End User
  • 8.2.5 United States
  • 8.2.6 Canada
  • 8.2.7 Mexico
• 8.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.3.1 By Product
  • 8.3.2 By Treatment
  • 8.3.3 By Indication
  • 8.3.4 By End User
  • 8.3.5 United Kingdom
  • 8.3.6 France
  • 8.3.7 Germany
  • 8.3.8 Italy
  • 8.3.9 Russia
  • 8.3.10 Rest Of Europe
• 8.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.4.1 By Product
  • 8.4.2 By Treatment
  • 8.4.3 By Indication
  • 8.4.4 By End User
  • 8.4.5 India
  • 8.4.6 Japan
  • 8.4.7 South Korea
  • 8.4.8 Australia
  • 8.4.9 South East Asia
  • 8.4.10 Rest Of Asia Pacific
• 8.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.5.1 By Product
  • 8.5.2 By Treatment
  • 8.5.3 By Indication
  • 8.5.4 By End User
  • 8.5.5 Brazil
  • 8.5.6 Argentina
  • 8.5.7 Peru
  • 8.5.8 Chile
  • 8.5.9 South East Asia
  • 8.5.10 Rest of Latin America
• 8.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.6.1 By Product
  • 8.6.2 By Treatment
  • 8.6.3 By Indication
  • 8.6.4 By End User
  • 8.6.5 Saudi Arabia
  • 8.6.6 UAE
  • 8.6.7 Israel
  • 8.6.8 South Africa
  • 8.6.9 Rest of the Middle East And Africa

Chapter 9. COMPETITIVE LANDSCAPE

• 9.1. Recent Developments
• 9.2. Company Categorization
• 9.3. Supply Chain & Channel Partners (based on availability)
• 9.4. Market Share & Positioning Analysis (based on availability)
• 9.5. Vendor Landscape (based on availability)
• 9.6. Strategy Mapping

Chapter 10. COMPANY PROFILES OF GLOBAL EMBOLIZATION DEVICES FOR NEUROLOGY INDUSTRY

• 10.1. Top Companies Market Share Analysis
• 10.2. Company Profiles
  • 10.2.1 Johnson & Johnson
  • 10.2.2 Abbott Laboratories
  • 10.2.3 Medtronic Plc
  • 10.2.4 Heraeus Holding
  • 10.2.5 Stryker Corporation
  • 10.2.6 Boston Scientific Corporation
  • 10.2.7 Kaneka Corporation
  • 10.2.8 Terumo Corporation
  • 10.2.9 B. Braun Melsungen AG
  • 10.2.10 Cook Medical LLC
  • 10.2.11 Integer Holdings Corporation
  • 10.2.12 Merit Medical Systems Inc
  • 10.2.13 Penumbra Inc
  • 10.2.14 Asahi Intecc Co. Ltd
  • 10.2.15 MicroVention Inc